跳至主要内容
临床试验/CTRI/2022/04/041628
CTRI/2022/04/041628尚未招募未知

A Study to assess alteration in plasma levels of miRNA-132 and miRNA-134 after treatment in patients with obsessive-compulsive disorder

Medical Research Unit0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • i.Meeting the criteria of the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) presented by the American Psychiatric Association (Washington, D.C., USA)
  • ii.Aged between 16 and 50 years old
  • iii.A YaleBrown Obsessive-Compulsive Scale (Y-BOCS) score >16 points; for simple obsessive or forced behavior, a Y-BOCS score >8 points.
  • iv.No other major mental illnesses.
  • v.No history of psychiatric drug use.
  • vi.Give written informed consent.

排除标准

  • i.A history of organic brain disease or serious physical illness, symptoms of psychosis, or a history of other mental illnesses
  • ii.Severe depression (a Hamilton Depression Rating Scale (HAMD) score >35 points)
  • iii.Second-generation with a family history of mental illness.

研究者

发起方
Medical Research Unit

相似试验